Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where F. Güçlü Pınarlı is active.

Publication


Featured researches published by F. Güçlü Pınarlı.


Pediatric Blood & Cancer | 2005

Late cardiac evaluation of children with solid tumors after anthracycline chemotherapy.

F. Güçlü Pınarlı; Aynur Oguz; F. Sedef Tunaoglu; Ceyda Karadeniz; Nahide Gökçora; Şehri Elbeg

The therapeutic potential of anthracycline antibiotics is limited by their cardiotoxicity. Electrocardiography, exercise testing, and two‐dimensional echocardiography are non‐invasive techniques used in the follow‐up of children for cardiotoxicity. Plasma B‐type natriuretic peptide (BNP) levels are thought to be useful markers in the early detection of AC induced cardiomyopathy.


Pediatric Blood & Cancer | 2007

Complementary/alternative medicine use in a pediatric oncology unit in Turkey

Ceyda Karadeniz; F. Güçlü Pınarlı; Aynur Oguz; Türkiz Gürsel; Berna Canter

Important in the cancer therapy is the increasingly use of complementary/alternative medicine (CAM). The current study aims to establish the extent of use, the types of therapies employed, factors influencing, the reasons for choosing and the cost of CAM used in pediatric cancer patients in our clinic in Ankara, Turkey.


Pediatric Blood & Cancer | 2005

Prognostic factors and treatment outcome in childhood hodgkin disease

Aynur Oguz; Ceyda Karadeniz; F. Visal Okur; E. Çağlar Çitak; F. Güçlü Pınarlı; Huseyin Bora; Nalan Akyürek

The goals of this study included: (1) Identification of factors prognostic for event‐free survival (EFS) and overall survival (OS), and (2) Definition of risk groups for risk adapted therapy in children with Hodgkin disease (HD).


European Journal of Echocardiography | 2010

Early diagnosis of anthracycline toxicity in asymptomatic long-term survivors: dobutamine stress echocardiography and tissue Doppler velocities in normal and abnormal myocardial wall motion

Ayşe Yıldırım; F. Sedef Tunaoglu; F. Güçlü Pınarlı; Mustafa N. Ilhan; Aynur Oguz; Ceyda Karadeniz; Rana Olguntürk; Deniz Oguz; Serdar Kula

AIMS Asymptomatic long-term cancer survivors treated with anthracycline were investigated for late anthracycline cardiotoxicity using dobutamine stress echocardiography (DSE) and tissue Doppler (TD) velocities. METHODS AND RESULTS The study comprised 20 asymptomatic patient and 18 healthy children as the control group. Twenty patients were divided into two groups according to the myocardial wall motion during DSE: Group 1 (normal myocardial wall motion; six girls and five boys) and Group 2 (abnormal myocardial wall motion: nine boys). Intravenous dobutamine infusion was started at a dose of 5 µg/kg/min (D5) and gradually increased to 10 (D10), 15 (D15) and 20 µg/kg/min (D20). Echocardiographic assessment was performed at rest and after each dose of dobutamine infusion. Abnormal myocardial wall motion was observed at rest in 3 patients and during DSE in six patients. There were no significant differences between the patients and control groups at rest except the end systolic wall stress and mitral deceleration time measured by conventional methods; however, both patients group showed significant differences of systolic and diastolic functions at D20. In patients groups, systolic and diastolic functions of interventricular septum (IVS) and systolic function of left ventricle (LV) and right ventricle (RV) TD velocities showed significant changes compared with control group at rest. Significant differences of diastolic functions of IVS and RV were noted during dobutamine infusion in abnormal myocardial wall motion compared with other groups. CONCLUSION LV, RV and IVS TD velocities systolic function at rest and during DSE can provide valuable information for early detection of subclinical cardiac toxicity. TD velocities of diastolic functions during DSE are a valuable parameter for assessment of subclinical cardiac toxicity in patient with abnormal wall motion.


Pediatric Hematology and Oncology | 2005

TYPE II PLEUROPULMONARY BLASTOMA RESPONSIVE TO MULTIMODAL THERAPY

F. Güçlü Pınarlı; Aynur Oguz; Ceyda Karadeniz; Leyla Memis; Aylar Poyraz

Pleuropulmonary blastoma is a rare and aggressive primary intrathoracic neoplasm of children. The prognosis is extremely poor with frequent metastasis to the brain and bone. A 4-year-old boy successfully treated with multimodal therapy despite unfavorable prognostic factors is presented. The authors support the use of aggressive treatment of pleuropulmonary blastoma with surgery, chemotherapy, and radiotherapy.


Brain & Development | 2010

Is oxidative damage in operation in patients with hereditary spastic paraparesis

F. Güçlü Pınarlı; Deniz Erbas; Alev Hasanoglu; Ayse Serdaroglu; Haluk Topaloglu

Oxidative stress resulting from increased free radical production and/or defects in antioxidant defences may be the cause of various neurodegenerative disorders. In this study, the roles of oxygen free radicals, nitric oxide, superoxide dismutase, vitamin E and vitamin C were investigated in pure and complicated hereditary spastic paraparesis (HSP) patients. The results showed that plasma SOD, vitamin E and nitric oxide levels were significantly low in HSP patients. These findings indicate the influence of oxidative damage in the degenerative process of HSP.


Pediatric Hematology and Oncology | 2004

SECOND PRIMARY MYOGENIC SARCOMA IN A PATIENT WITH BILATERAL RETINOBLASTOMA

F. Güçlü Pınarlı; Aynur Oguz; Ceyda Karadeniz; Ömer Uluoğlu; Nalan Akyürek

Retinoblastoma is the primary ocular malignancy affecting children under 6 years of age. The development of second malignant tumors in survivors of hereditary retinoblastoma is a well-known clinical entity and a major cause of morbidity and mortality. Rhabdomyosarcomas as second primary tumors have been only rarely described. The authors report a patient with bilateral retinoblastoma who developed a myogenic sarcoma of the orbit after 5.5 years of diagnosis. The short latency period may be explained by tumor histology with the contribution of radiotherapy and chemotherapy. The prognosis of second tumors is poor despite aggressive treatment.


Pediatric Cardiology | 2010

Tissue and Flow Myocardial Performance Index Measurements Taken During Dobutamine Stress Echocardiography for Early Diagnosis of Late Anthracycline Cardiotoxicity

Ayşe Yıldırım; F. Sedef Tunaoglu; F. Güçlü Pınarlı; Mustafa N. Ilhan; Aynur Oguz; Ceyda Karadeniz; Rana Olguntürk; Deniz Oguz; Serdar Kula


Kardiologia Polska | 2013

The utility of NT−proBNP and various echocardiographic methods in the determination of doxorubicin induced subclinical late cardiotoxicity

Ayşe Yıldırım; F. Sedef Tunaoglu; Kenan Kanburoglu; F. Güçlü Pınarlı


Leukemia & Lymphoma | 2006

Late effects of treatment on growth in childhood non-Hodgkin's lymphoma

Aynur Oguz; F. Güçlü Pınarlı; Ceyda Karadeniz; Aysun Bideci; Seçil Özkan

Collaboration


Dive into the F. Güçlü Pınarlı's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge